Literature DB >> 6986008

Idiopathic hemochromatosis, an interim report.

M S Milder, J D Cook, S Stray, C A Finch.   

Abstract

Experience over the last 20 years with 34 patients with idiopathic hemochromatosis is summarized and the literature is reviewed. Methods are now available which are highly effective in the diagnosis of iron overload and virtually all diagnoses are made antemortem. The nature of the disease has changed through the removal of iron by phlebotomy. Early deaths are limited to patients with severe and rapidly progressive heart disease and to those presenting with neoplasm. The major mortality has shifted to a much later period and the incidence of hepatoma is increasing. There is particular interest at the present time in family studies since excessive iron stores are frequently found within the family. The significance of intermediate degrees of iron overload is unclear, but future attention should be given to the recognition of iron overload long before clinical manifestations appear.

Entities:  

Mesh:

Year:  1980        PMID: 6986008     DOI: 10.1097/00005792-198001000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  29 in total

1.  Orthotopic liver transplantation for hemochromatosis.

Authors:  P Pillay; E Tzoracoleftherakis; A G Tzakis; S Kakizoe; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1991-04       Impact factor: 1.066

2.  Hypogonadotropic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement.

Authors:  K Siminoski; M D'Costa; P G Walfish
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

3.  Dietary and prophylactic iron supplements : Helpful or harmful?

Authors:  S Kent; E D Weinberg; P Stuart-Macadam
Journal:  Hum Nat       Date:  1990-03

Review 4.  The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

Authors:  David S Goldberg; Michael B Fallon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-28       Impact factor: 11.382

5.  In vitro antiproliferative activity of 2'-(2-hydroxyphenyl)-2'-thiazoline-4'-carboxylic acid and its methyl ester on L1210 and P388 murine neoplasms.

Authors:  G T Elliot; K F Kelly; R L Bonna; T R Wardlaw; E R Burns
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

6.  HODGKIN'S DISEASE WITH IDIOPATHIC HEMOCHROMATOSIS.

Authors:  G U Deshpande; A C Anand; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 7.  Bone biopsy in haematological disorders.

Authors:  R Burkhardt; B Frisch; R Bartl
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

8.  Idiopathic familial hemochromatosis: limited disease extent with prolonged survival and arthritis.

Authors:  J L De Greve; L A Verbruggen; D Schallier; B Van Camp
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

9.  HFE mutations in heart disease.

Authors:  Terence Dunn; Derek Blankenship; Nicole Beal; Richard Allen; Eliot Schechter; William Moore; Ghazala Perveen; June Eichner
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

10.  Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism.

Authors:  M Cazzola; E Ascari; G Barosi; G Claudiani; M Daccó; J P Kaltwasser; N Panaiotopoulos; K P Schalk; E E Werner
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.